首页> 外文期刊>Hemodialysis international >Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis
【24h】

Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis

机译:透析前和透析后血浆钠的变化比quotidian血液透析中透析液对血浆钠梯度的变化更好地预测临床结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Sodium balance across a hemodialysis treatment influences interdialytic weight gain (IDWG), pre-dialysis blood pressure, and the occurrence of intradialytic hypotension, which associate with patient morbidity and mortality. In thrice weekly conventional hemodialysis patients, the dialysate sodium minus pre-dialysis plasma sodium concentration (δDPNa+) and the post-dialysis minus pre-dialysis plasma sodium (δPNa+) are surrogates of sodium balance, and are associated with both cardiovascular and all-cause mortality. However, whether δDPNa+ or δPNa+ better predicts clinical outcomes in quotidian dialysis is unknown. We performed a retrospective analysis of clinical and demographic data from the Southwestern Ontario Regional Home Hemodialysis program, of all patients since 1985. In frequent nocturnal hemodialysis, δPNa+ was superior to δDPNa+ in predicting IDWG (R2=0.223 vs. 0.020, P=0.002 vs. 0.76), intradialytic change in systolic (R2=0.100 vs. 0.002, P=0.02 vs. 0.16) and diastolic (R2=0.066 vs. 0.019, P=0.02 vs. 0.06) blood pressure, and ultrafiltration rate (R2=0.296 vs. 0.036, P=0.001 vs. 0.52). In short hours daily hemodialysis, δDPNa+ was better than δPNa+ in predicting intradialytic change in diastolic blood pressure (R2=0.101 vs. 0.003, P=0.02 vs. 0.13). However, δPNa+ was better than δDPNa+ in predicting IDWG (R2=0.105 vs. 0.019, P=0.04 vs. 0.68) and pre-dialysis systolic blood pressure (R2=0.103 vs. 0.007, P=0.02 vs. 0.82). We also found that the intradialytic blood pressure fall was greater in frequent nocturnal hemodialysis patients than in short hours daily patients, when exposed to a dialysate to plasma sodium gradient. These results provide a basis for design of prospective trials in quotidian dialysis modalities, to determine the effect of sodium balance on cardiovascular outcome.
机译:血液透析治疗中的钠平衡会影响透析间体重增加(IDWG),透析前血压和透析内低血压的发生,这与患者的发病率和死亡率有关。在每周三次的常规血液透析患者中​​,透析液钠减去透析前血浆钠浓度(δDPNa+)和透析后减去透析前血浆钠(δPNa+)是钠平衡的替代指标,与心血管和全因相关死亡。然而,尚不清楚δDPNa+或δPNa+能否更好地预测quotidian透析的临床结果。自1985年以来,我们对西南安大略地区家庭血液透析计划的所有患者进行了临床和人口统计数据的回顾性分析。在频繁的夜间血液透析中,在预测IDWG方面,δPNa+优于δDPNa+(R2 = 0.223 vs. 0.020,P = 0.002vs。 0.76),收缩压(R2 = 0.100 vs.0.002,P = 0.02 vs.0.16)和舒张压(R2 = 0.066 vs.0.019,P = 0.02 vs.0.06)和超滤率(R2 = 0.296)的透析内变化对比0.036,P = 0.001对比0.52)。在每日短时血液透析中,在预测舒张压的透析内变化方面,δDPNa+优于δPNa+(R2 = 0.101 vs. 0.003,P = 0.02 vs. 0.13)。然而,在预测IDWG(R2 = 0.105对0.019,P = 0.04对0.68)和透析前收缩压(R2 = 0.103对0.007,P = 0.02对0.82)方面,δPNa+优于δDPNa+。我们还发现,在频繁的夜间血液透析患者中​​,当透析液暴露于血浆钠梯度时,其透析内血压下降幅度要大于每日短时间的患者。这些结果为设计quotidian透析方式的前瞻性试验提供基础,以确定钠平衡对心血管预后的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号